Century Therapeutics (IPSC) Intangibles (2021 - 2026)
Century Therapeutics (IPSC) posted quarterly Intangibles of $34.2 million for Q1 2026, little changed year-over-year from $34.2 million in Q1 2025, and little changed quarter-over-quarter from $34.2 million in Q4 2025.
Century Therapeutics (IPSC) Intangibles (2021 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported Intangibles for 4 consecutive years, with $34.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Intangibles changed 0.0% year-over-year to $34.2 million; the TTM figure through Mar 2026 stood at $34.2 million (changed 0.0% YoY), while the FY2025 annual figure was $34.2 million, changed 0.0% from the prior year.
- Intangibles was little changed at $34.2 million in Q1 2026 per IPSC's latest filing, from $34.2 million in the prior quarter.
- Across five years, Intangibles topped out at $34.2 million in Q4 2024 and bottomed at $33.3 million in Q2 2024.
- Historically, Intangibles has averaged $34.0 million across 3 years, with a median of $34.2 million in 2024.
- On a YoY basis, Intangibles climbed as much as 2.7% in 2025 and fell as far as 0.0% in 2025.
- Century Therapeutics' Intangibles stood at $34.2 million in 2024, then changed by 0.0% to $34.2 million in 2025, then changed by 0.0% to $34.2 million in 2026.
- Business Quant data shows IPSC's Intangibles at $34.2 million in Q1 2026, $34.2 million in Q4 2025, and $34.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 266.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 63.28 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 60.96 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - | 34.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.20 Mn |
| Mar 31, 2026 | 34.20 Mn |
| Dec 31, 2025 | 34.20 Mn |
| Sep 30, 2025 | 34.20 Mn |
| Jun 30, 2025 | 34.20 Mn |
| Mar 31, 2025 | 34.20 Mn |
| Dec 31, 2024 | 34.20 Mn |
| Sep 30, 2024 | 33.80 Mn |
| Jun 30, 2024 | 33.30 Mn |
| Dec 31, 2021 | 4.72 Mn |